metformin has been researched along with Cancer of the Urinary Tract in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, X | 1 |
| Liu, H | 1 |
| Xu, H | 1 |
| Harishankar, MK | 1 |
| Logeshwaran, S | 1 |
| Sujeevan, S | 1 |
| Aruljothi, KN | 1 |
| Dannie, MA | 1 |
| Devi, A | 1 |
| Sayyid, RK | 1 |
| Fleshner, NE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Phytoecdysterone Administration on Cytotoxicity, Genotoxicity and Metabolic Control in Subjects With Prediabetes[NCT03906201] | 34 participants (Anticipated) | Interventional | 2019-02-06 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for metformin and Cancer of the Urinary Tract
| Article | Year |
|---|---|
The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
Topics: China; Humans; Hypoglycemic Agents; Kidney Neoplasms; Male; Metformin; Prognosis; Prostatic Neoplasm | 2021 |
Potential role for metformin in urologic oncology.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Mal | 2016 |
1 other study available for metformin and Cancer of the Urinary Tract
| Article | Year |
|---|---|
Genotoxicity evaluation of metformin and glimepiride by micronucleus assay in exfoliated urothelial cells of type 2 diabetes mellitus patients.
Topics: Adult; Aged; Biomarkers; Diabetes Mellitus, Type 2; DNA Damage; Drug Therapy, Combination; Female; G | 2015 |